New IBD research shows that, even during clinical remission, people living with Crohn's disease continue to experience ...

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European ...

Inflammatory Bowel Disease (IBD), according to the Mayo Clinic, is an umbrella term for a group of disease that include Ulcerative Colitis and Crohn's Disease. They cause "swelling and inflammation of ...

The 28-year-old defender is now supporting IBD research by the Royal Devon University Healthcare NHS Foundation Trust and the ...

Early in his career, San Francisco Giants first baseman J.T. Snow learned he had ulcerative colitis. Years later, it nearly ...

Returning to the game earlier this season after an 896-day hiatus as a result of an ulcerative colitis diagnosis, Ramsey has revealed his agonising and painstaking return to the footy field after ...

If you use an EpiPen or antihistamine to treat food allergies, it’s important to bring an adequate supply and to bring them ...

Ustekinumab is effective and safe and shows a high rate of clinical remission and treatment persistence in patients with ulcerative colitis.

Two leading G.I. doctors explain eight common reasons the experience doesn't feel like relief, and when it's not just a passing sensation. About the experts Adrienna Jirik, MD, is a board-certified ...

HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...

The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...

The FDA has expanded the approval of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis (UC) to include an SC induction regimen.